1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Closed-Angle Glaucoma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Closed-Angle Glaucoma Clinical Trials by Region
2.2.2 Average Enrollment of Closed-Angle Glaucoma Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Closed-Angle Glaucoma Treatment, 2019

3. Region wise Closed-Angle Glaucoma Clinical Trials
3.1 Asia Pacific Closed-Angle Glaucoma Clinical Trials by Country
3.2 Europe Closed-Angle Glaucoma Clinical Trials by Country
3.3 North America Closed-Angle Glaucoma Clinical Trials by Country
3.4 Middle East and Africa Closed-Angle Glaucoma Clinical Trials by Country
3.5 South and Central America Closed-Angle Glaucoma Clinical Trials by Country

4. Closed-Angle Glaucoma Clinical Trial Trends
4.1 Start Year wise Closed-Angle Glaucoma Clinical Trials
4.2 Phase wise Closed-Angle Glaucoma Clinical Trials
4.3 Trial Status wise Closed-Angle Glaucoma Clinical Trials
4.4 Trial Type wise Closed-Angle Glaucoma Clinical Trials

5. Closed-Angle Glaucoma Average Enrollment Trends
5.1 Average Enrollment in Closed-Angle Glaucoma Trials by Year
5.2 Average Enrollment in Closed-Angle Glaucoma Trials by Phase
5.3 Average Enrollment in Closed-Angle Glaucoma Trials by Status
5.4 Average Enrollment in Closed-Angle Glaucoma Trials by Type of Trial

6. Companies Participating in Closed-Angle Glaucoma Clinical Trials
6.1 Closed-Angle Glaucoma Trials by Sponsor Type
6.2 Closed-Angle Glaucoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Closed-Angle Glaucoma Trials- Phase 1
7.2 Closed-Angle Glaucoma Trials- Phase 2
7.3 Closed-Angle Glaucoma Trials- Phase 3
7.4 Closed-Angle Glaucoma Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Closed-Angle Glaucoma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Figure 7: North America – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Figure 9: Closed-Angle Glaucoma Clinical Trials by Phase
Figure 10: Closed-Angle Glaucoma Clinical Trials by Trial Status
Figure 11: Closed-Angle Glaucoma Clinical Trials by Type
Figure 12: Closed-Angle Glaucoma Clinical Trials by Sponsor Type
Figure 13: Closed-Angle Glaucoma Clinical Trials by Leading Sponsors
Figure 14: Closed-Angle Glaucoma Average Enrollment by Phase
Figure 15: Closed-Angle Glaucoma Average Enrollment by Trial Status
Figure 16: Closed-Angle Glaucoma Average Enrollment by Type
Figure 17: Closed-Angle Glaucoma- Average Enrolment by Type of Sponsors
Figure 18: Closed-Angle Glaucoma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Closed-Angle Glaucoma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Table 5: Europe – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Table 7: North America – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Closed-Angle Glaucoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Closed-Angle Glaucoma Average Enrollment by Phase
Table 15: Closed-Angle Glaucoma Average Enrollment by Trial Status
Table 16: Closed-Angle Glaucoma Average Enrollment by Type
Table 17: Closed-Angle Glaucoma- Average Enrolment by Type of Sponsors
Table 18: Closed-Angle Glaucoma- Enrolment by Leading Sponsors

Companies mentioned
Aerie Pharmaceuticals Inc, Allergan Plc, Novartis AG, Pro Top and Mediking Co Ltd, Santen Pharmaceutical Co Ltd, SBI Biotech Co Ltd, Sun Pharmaceutical Industries Ltd